BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14574913)

  • 1. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
    Motomura S
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
    Bleiberg H; Di Leo A
    J Clin Oncol; 2002 Feb; 20(4):1145-6. PubMed ID: 11844840
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer.
    Alimonti A; Satta F; Pavese I; Burattini E; Zoffoli V; Vecchione A
    Ann Oncol; 2003 May; 14(5):805-6. PubMed ID: 12702539
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer.
    Chico IM; Pazdur R
    Clin Colorectal Cancer; 2002 May; 2(1):11-2. PubMed ID: 12453329
    [No Abstract]   [Full Text] [Related]  

  • 7. Irinotecan/5-fluorouracil/leucovorin in advanced colorectal cancer: Oncologic Drugs Advisory committee summary.
    Oncologic Drugs Advisory Committee
    Clin Colorectal Cancer; 2002 May; 2(1):8-10. PubMed ID: 12453328
    [No Abstract]   [Full Text] [Related]  

  • 8. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 9. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
    Hwang JJ
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G; Fietkau R
    Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
    [No Abstract]   [Full Text] [Related]  

  • 13. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pestalozzi BC
    N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):718-9. PubMed ID: 17274384
    [No Abstract]   [Full Text] [Related]  

  • 15. [Capecitabine and irinotecan].
    Gasperoni S
    Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.
    Liu JH
    Clin Colorectal Cancer; 2004 Sep; 4(3):204-5. PubMed ID: 15377404
    [No Abstract]   [Full Text] [Related]  

  • 17. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C; Goldberg RM; O'Connell MJ
    N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of adjuvant chemotherapy irinotecan + 5-fluorouracil + leucovorine in advanced colorectal cancer.
    Kulig J; Popiela T; Richter P; Klek S
    Acta Chir Belg; 2007 Jun; 107(3):297-301. PubMed ID: 17685257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving beyond fluorouracil for colorectal cancer.
    Mayer RJ
    N Engl J Med; 2000 Sep; 343(13):963-4. PubMed ID: 11006373
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant irinotecan regimens in combination with infusional 5-fluorouracil/leucovorin fail to improve outcomes in surgically resected colorectal cancer.
    Tyagi P
    Clin Colorectal Cancer; 2005 Jul; 5(2):86-8. PubMed ID: 16098248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.